PT Prodia Diagnostic Line Tbk (PRDL) has successfully completed its initial public offering on the Indonesia Stock Exchange, raising Rp 62.74 billion ($3.9 million) in its debut listing.
The shares surged 35% on the first day of trading, reflecting robust investor demand for the country's largest diagnostic laboratory network.
The 35% jump on debut highlights the premium placed on established diagnostic providers with scalable operational models.
The listing marks a significant milestone for the Prodia Group, which operates an extensive network of laboratories across Indonesia.
The company stated that proceeds from the offering will be deployed to strengthen business expansion and industrial capabilities, supporting its growth trajectory in the domestic healthcare sector.
The strong market reception underscores continued investor interest in Indonesian healthcare infrastructure, even as global IPO activity remains selective.
The 35% jump on debut highlights the premium placed on established diagnostic providers with scalable operational models.